Physician profile
Alyson D Miser
NPI 1811080419
$4,256.71
in general payments reported to CMS, 2019-2025
20 companies · $636 in 2025
The $636 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.44 · 2020: $87.35 · 2021: $143 · 2022: $275 · 2023: $2,543 · 2024: $474 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,974 · Travel and Lodging: $1,593 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,974.03 |
| Travel and Lodging | $1,593.38 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Modernatx, INC. | $2,195.97 | 2023 | |
| Abbvie INC. | $1,112.37 | 2019-2025 | |
| Astellas Pharma US INC | $234.21 | 2023-2025 | Veozah, Myrbetriq |
| Organon LLC | $123.14 | 2021-2025 | Nexplanon |
| Daiichi Sankyo INC. | $99.13 | 2019-2025 | Injectafer |
| Hologic Sales and Service, LLC | $86.65 | 2019-2025 | Coolseal Generator, Acessa Provu System, Myosure Tissue Removal Device |
| Merck Sharp & Dohme LLC | $77.81 | 2019-2021 | |
| Sage Therapeutics, LLC | $64.35 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $48.13 | 2023-2024 | Cologuard Collection Kit |
| Becton, Dickinson and Company | $31.17 | 2025 | Channel Drain |
| Coopersurgical, INC. | $30.81 | 2022-2025 | Paragard T 380a |
| Coloplast Corp | $29.32 | 2024 | |
| Conmed Corporation | $22.77 | 2024 | Airseal |
| Channel Medsystems, INC. | $21.97 | 2023 | |
| Minerva Surgical, INC | $17.71 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $17.37 | 2025 | Qelbree |
| Octapharma USA, INC. | $15.85 | 2025 | Fibryga |
| Axonics, INC. | $14.37 | 2022 | |
| Lilly USA, LLC | $13.61 | 2024 | Jardiance, Zepbound |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyson Miser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.